SSC
CDNA icon

Syverson Strege & Co’s CareDx CDNA Stock Holding History

Syverson Strege & Co’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed -$9K – 303
2021
Q4 		$9K Hold
200
– – 0.01% 206
2021
Q3 		$13K Hold
200
– – 0.01% 214
2021
Q2 		$18K Buy
+200
New +$15.9K 0.02% 176

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Syverson Strege & Co's CDNA Position: Q1 2022 in Review

Syverson Strege & Co sold out of CareDx (CDNA) in Q1 2022, closing a stake of 200 shares — an estimated $9K sold.

Syverson Strege & Co first reported a position in CDNA in Q2 2021 and held it in 3 quarters. The position peaked at $18K in Q2 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Syverson Strege & Co reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Syverson Strege & Co sold 200 CareDx shares in Q1 2022, an estimated $9K.
  • Syverson Strege & Co first reported a position in CareDx in Q2 2021 and held it in 3 quarters.
  • Syverson Strege & Co's CareDx position peaked at $18K in Q2 2021.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Syverson Strege & Co's 13F filing for Q1 2022, filed 13 Apr 2022.